Home
/
Protara Therapeutics, Inc.
/
Financials
/
Quarterly
Protara Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Protara Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2015
Sep 30, 2014
$2.95M
Nov 12, 2015
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($13.26M)
Nov 10, 2025
Q3
2025
Jun 30, 2025
($14.96M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($14.96M)
Aug 11, 2025
Q3
2025
Mar 31, 2025
($11.91M)
Nov 10, 2025
Q2
2025
Mar 31, 2025
($11.91M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($11.91M)
May 8, 2025
Q3
2025
Sep 30, 2024
($11.22M)
Nov 10, 2025
Q3
2025
Jun 30, 2024
($9.51M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($9.51M)
Aug 11, 2025
Q2
2025
Mar 31, 2024
($11.10M)
Aug 11, 2025
Q3
2025
Mar 31, 2024
($11.10M)
Nov 10, 2025
Q1
2025
Mar 31, 2024
($11.10M)
May 8, 2025
Q3
2024
Sep 30, 2023
($9.86M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($11.29M)
Aug 6, 2024
Q3
2024
Jun 30, 2023
($11.29M)
Nov 12, 2024
Q1
2024
Mar 31, 2023
($9.05M)
May 2, 2024
Q3
2024
Mar 31, 2023
($9.05M)
Nov 12, 2024
Q2
2024
Mar 31, 2023
($9.05M)
Aug 6, 2024
Q3
2023
Sep 30, 2022
($7.69M)
Nov 3, 2023
Q2
2023
Jun 30, 2022
($8.54M)
Aug 3, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($14.76M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($16.59M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($14.12M)
May 8, 2025
Q3
2025
Sep 30, 2024
($12.33M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($10.66M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($11.85M)
May 8, 2025
Q3
2024
Sep 30, 2023
($10.70M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($12.14M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($9.73M)
May 2, 2024
Q3
2023
Sep 30, 2022
($7.97M)
Nov 3, 2023
Q2
2023
Jun 30, 2022
($8.71M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($10.87M)
May 4, 2023
Q3
2022
Sep 30, 2021
($10.83M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($12.79M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($13.58M)
May 5, 2022
Q3
2021
Sep 30, 2020
($8.06M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($7.27M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($10.16M)
May 6, 2021
Q3
2020
Sep 30, 2019
($2.35M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($1.43M)
Jul 31, 2020